Asia
China’s Hillhouse Capital Group, an equity investment firm, has a new fund, Hillhouse Fund IV, with $10.6 billion ready to invest.
Management will host a conference call and webcast today, Monday, 17 September at 8:30am ET/8:30pm SGT.
New report highlights major gaps in understanding and significant misperceptions about blood cancer in the region, with one in two Japanese and one in four Chinese unable to name a single symptom of the disease
Han expounds on his Theory of Negative Trigger as it relates to seasonal/yearlong allergies.
BeiGene to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies
CBT Pharmaceuticalstoday announced the initiation of the APOLLO Oncology Clinical Trials Program.
A second former GlaxoSmithKline scientist has pled guilty to stealing trade secrets as part of a scheme to benefit a startup China-based pharmaceutical company he helped establish.
Allergan and its development partner Sosei Group have voluntarily suspended clinical trials of HTL0018318 in Alzheimer’s and other types of dementia because of safety problems.
Novo Nordisk is laying off 400 staffers so it can shift funds toward biological and technological innovation.
Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs
PRESS RELEASES